MDCalc

Mayo Alliance Prognostic System (MAPS) Score

Evaluates prognosis of systemic mastocytosis.

SM type

Age, years

Platelets

Serum ALP

Adverse mutations

(i.e., ASXL1, RUNX1, NRAS)

Result:

Please fill out required fields.
Advice
  • A higher score is associated with a poorer prognosis.
  • Results should be integrated into a comprehensive evaluation to inform management decisions, such as opting for more aggressive treatment strategies when necessary.